The London Psychiatry Centre

What The London Psychiatry Centre does

The London Psychiatry Centre is a private for-profit psychiatric clinic headquartered at 72 Harley Street, London W1G 7HG, founded in 2012 by Dr Andy Zamar. Operating with 11-50 employees, the clinic pioneered the use of repetitive Transcranial Magnetic Stimulation (rTMS) in the UK and offers a broad mental health portfolio spanning treatment-resistant depression, bipolar spectrum disorder (types I, II, subthreshold, and rapid cycling), ADHD, anxiety, trauma/PTSD (EMDR), OCD, fibromyalgia, tinnitus, substance use disorder, perinatal mental health, and child & adolescent mental health services. The core product is repetitive Transcranial Magnetic Stimulation, a non-invasive technique that uses pulsed magnetic fields to stimulate the dorsolateral prefrontal cortex (DLPFC).

The clinic's differentiation rests on The Zamar Protocol®, a patented precision-medicine protocol combining high-dose levothyroxine with rTMS, supported by genetic testing (mouth swab), blood analysis, and ECG. The clinic reports a 96.4% full remission rate across the bipolar spectrum with The Zamar Protocol (over an average two-year observation period) and 61-66% remission rates for rTMS in treatment-resistant depression — double the rate of dTMS providers and triple the UK rTMS platinum standard with neuronavigation. The protocol is the only evidence-based treatment for subthreshold bipolar disorder and is the subject of a granted EP unitary patent (July 2023); a pending patent covers genetic biomarkers that could yield the first laboratory diagnostic test for Bipolar Spectrum Disorder, with King's College London commissioned for replication.

The business model is private pay plus insurance reimbursement on a pay-and-claim-back basis. Initial psychiatrist assessments are £600, and rTMS sessions are £400 each, typically delivered at five sessions per week for four to six weeks. The Zamar Protocol is offered as a concierge service priced case-by-case. Distribution is direct via the clinic website, online booking, and telephone inquiries, with a 2024 partnership with Emirates Hospitals Group extending rTMS reach into Dubai. The clinic is CQC-regulated, is the only UK operation to publish rTMS outcomes in open-access peer-reviewed journals, and served as a NICE clinical specialist adviser on rTMS approval.

Name

The London Psychiatry Centre

Legal name

The London Psychiatry Centre

Website

https://psychiatrycentre.co.uk

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

The London Psychiatry Centre is a Harley Street private psychiatric clinic founded in 2012 that pioneered rTMS in the UK and offers The Zamar Protocol, a patented precision-medicine protocol combining high-dose levothyroxine with rTMS, primarily serving adults with treatment-resistant depression and bipolar spectrum disorders via private pay and insurance reimbursement.

Ownership category

akta.pro rank

Product category

Private psychiatric and mental health services

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)

akta.pro secondary industry

Outpatient Mental Health & Counseling Clinics (HLAFABAC)

Keywords

• Private psychiatric clinic
• RTMS treatment
• Treatment-resistant depression
• Bipolar disorder treatment
• Precision medicine psychiatry

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Private Consultation and Assessment Fees: The clinic operates as a private pay and insurance-reclaimable mental health service. Initial assessments with a psychiatrist are charged at £600. Weekly review appointments with the rTMS consultant are required to re-prescribe and monitor treatment. The Zamar Protocol is offered as a concierge service on a case-by-case basis.
2. rTMS Treatment Sessions: rTMS sessions are charged at £400 per session. Patients undergo five sessions per week for an average of four to six weeks. Weekly review appointments with the rTMS consultant are required. The centre operates a pay-and-claim-back policy for insurers.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

The London Psychiatry Centre is a Harley Street private psychiatric clinic that delivers outpatient mental health treatment, principally repetitive Transcranial Magnetic Stimulation (rTMS) and the patented Zamar Protocol (precision-guided high-dose levothyroxine combined with rTMS). It also offers psychiatric assessments, EMDR, cognitive-behavioural and marital therapy, genetic testing, child and adolescent mental health services, addiction treatment, and concierge-level bespoke care on a self-pay and insurance claim-back basis.

Product overview

The London Psychiatry Centre is a Harley Street-based full-service private psychiatric clinic offering a comprehensive portfolio of mental health treatments. The core offerings include rTMS (Repetitive Transcranial Magnetic Stimulation), pioneered in the UK since 2012, and the proprietary Zamar Protocol® combining precision-guided high-dose thyroid hormones with rTMS for bipolar spectrum disorders and treatment-resistant depression. Additional services span ADHD, anxiety, addiction, trauma (EMDR), depression, child & adolescent mental health, genetic testing, naturopathic nutrition, cardiology, and Couples therapy. The centre operates a Treatment-Resistant Depression/Bipolar Clinic offering The Zamar Protocol® exclusively, alongside general psychiatry services and concierge mental health offerings.

Differentiator

Problem solved

Functional benefit

Brands

• The Zamar Protocol: A patented treatment protocol combining precision-guided high-dose thyroid hormones and rTMS for treatment-resistant depression and bipolar spectrum disorders.

Products and services

• Repetitive Transcranial Magnetic Stimulation (rTMS) Non-invasive, drug-free treatment using magnetic stimulation to target the dorsolateral prefrontal cortex (DLPFC) for depression, OCD, fibromyalgia, tinnitus, ADHD, and substance use disorder. Pioneered in the UK by The London Psychiatry Centre since 2012.
• The Zamar Protocol® Patented precision medicine treatment combining precision-guided high-dose levothyroxine with rTMS and mitochondrial treatment for bipolar spectrum disorders and treatment-resistant depression. Reported 96.4% full remission rate across the bipolar spectrum; only evidence-based treatment for subthreshold bipolar disorder.
• Depression Treatment Treatment for major depressive disorder and clinical depression, including treatment-resistant depression, using rTMS and other evidence-based approaches.
• Treatment-Resistant Depression (TRD) Clinic Specialised clinic for patients who have not responded to multiple antidepressant trials, offering rTMS and The Zamar Protocol.
• ADHD Assessment and Treatment Diagnosis and management of Attention Deficit Hyperactivity Disorder in both children and adults, addressing difficulties in regulating attention, hyperactivity, and impulsivity.
• EMDR (Eye Movement Desensitisation and Reprocessing) First-line treatment for trauma victims using eye movement desensitisation and reprocessing to process traumatic experiences.
• Anxiety Disorders Treatment Treatment for anxiety disorders including sudden episodes and long-term anxiety affecting stability and peace of mind.
• Addiction Treatment Treatment for substance use disorders including alcohol, gambling, and prescription drug addiction, using rTMS and talking therapies.
• Child & Adolescent Mental Health Services (CAMHS) Mental health services for children and young people experiencing emotional and behavioural problems, including ADHD in children.
• Genetic Testing for Better Mental Health Genetic testing to identify biomarkers and predict medication compatibilities, enabling personalised treatment approaches.
• Concierge Mental Health Services Bespoke, personalised mental health treatment plans offering first-class care tailored to individual needs.
• Fibromyalgia Treatment with rTMS Treatment for fibromyalgia using rTMS to manage widespread pain, severe fatigue, and chronic sleep disruption.
• Tinnitus Treatment with rTMS rTMS treatment for tinnitus (ringing in ears), with the clinic positioning as the only UK provider of rTMS for this condition.
• OCD Treatment with rTMS Treatment for obsessive compulsive disorder using rTMS as an alternative when CBT and medication have been unsuccessful.
• Substance Use Disorder Treatment with rTMS Treatment for substance use disorder using rTMS to manage cravings, particularly effective for stimulant substances.
• Naturopathic Nutrition Nutritional therapy integrated into mental health treatment programmes.
• Perinatal Mental Health & Preconception Advice Specialised mental health support during pregnancy and the perinatal period, including rTMS during pregnancy.
• Early Intervention Cardiology Preventative cardiology services integrated with mental health treatment, addressing cardiovascular risk in mood disorder patients.
• External Trigeminal Nerve Stimulation (eTNS) Non-invasive neuromodulation treatment for psychiatric conditions.
• Marital & Couples Therapy Therapy services for couples experiencing relationship difficulties.
• Mild Cognitive Impairment (MCI) Treatment Treatment and management of mild cognitive impairment.
• Seasonal Affective Disorder (SAD) Treatment Treatment for seasonal affective disorder using light therapy and other approaches.
• Bipolar Disorder Treatment Programme Comprehensive treatment programme for bipolar I, II, subthreshold bipolar disorder, and rapid cycling, using The Zamar Protocol combining precision medicine, mitochondrial treatment, high-dose levothyroxine, and rTMS.

Quantifiable outcome

• 96.4% full remission rate with The Zamar Protocol across bipolar spectrum disorders (type I, II, subthreshold, rapid cycling) over an average observation period of 2 years
• +9 more outcomes

Named customers2 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• Emirates Hospitals Group (EHG)coreStrategic or Co-development PartnerThe London Psychiatry Centre announced a partnership with Emirates Hospitals Group to introduce the first rTMS-based liaison service in the world. This cutting-edge psychiatric service will be rolled out across EHG facilities in Dubai to improve patient outcomes, aligned with a DH105 million mental health initiative to support residents of Dubai. The centre provides its rTMS expertise, protocols, and training to EHG.
• Academy of Brain Stimulation, Maastricht UniversityflagshipStrategic or Co-development PartnerThe Zamar Protocol has been incorporated into the prestigious TMS International Clinical Certification Course of The Academy of Brain Stimulation at Maastricht University. Dr Andy Zamar presents a module on The Zamar Protocol and rTMS for the treatment of bipolar spectrum disorders. This accredited course is widely considered the gold standard in TMS training, expanding the centre's global academic influence.
• King's College LondoncoreStrategic or Co-development PartnerKing's College London has been commissioned by The London Psychiatry Centre to conduct a larger independent replication study to validate the discovery of new genetic biomarkers in Bipolar Spectrum Disorder. The biomarkers were discovered by Dr Andy Zamar and his research team and published in the Journal of Personalized Medicine. The hope is that a lab test may be available within three years.

Scale indicators8 records

Recent moves6 records

Expansion highlights10 records

Emerging players

• Akeso Health / Oxford Brain Stimulation Centre: UK-based specialist rTMS providers offering transcranial magnetic stimulation for depression and related conditions. Comparable as emerging competitors in the UK private rTMS market, with overlapping but more limited service menus.
• Neurocare London: London-based private clinic offering TMS, neurofeedback, and integrative mental health therapies. Comparable as a newer specialist neuromodulation provider competing in the same London premium outpatient segment.

Direct peers

• The Kusnacht Practice: Premium Swiss private psychiatric and addiction treatment clinic offering bespoke, concierge-level mental health care for international clients. Comparable as a high-end international psychiatric practice targeting affluent self-pay patients with treatment-resistant conditions.
• Smart TMS: UK-based private rTMS clinic chain offering repetitive transcranial magnetic stimulation for depression, anxiety, OCD, and other conditions. Most direct competitor in the UK rTMS market that The London Psychiatry Centre pioneered.
• Nightingale Hospital London: Private mental health hospital in central London offering outpatient psychiatric consultations, therapy, and inpatient care for depression, anxiety, addiction, and eating disorders. Closely comparable premium London outpatient psychiatry competitor.

Others

• Magstim: UK-based manufacturer of transcranial magnetic stimulation systems used in clinical and research rTMS applications. Comparable as the upstream equipment provider in the rTMS value chain on which The London Psychiatry Centre's treatment depends.
• Bethlem Royal Hospital (South London and Maudsley NHS Foundation Trust): UK's premier psychiatric hospital and home of The Maudsley Prescribing Guidelines. Relevant as the academic and clinical reference standard cited in The London Psychiatry Centre's protocol listings, though NHS/public sector rather than direct commercial competitor.

Broad incumbents

• The Priory Group: One of the UK's largest private mental health and behavioural care providers, offering inpatient, outpatient, and day-care psychiatric services across multiple sites. Comparable as a premium UK private psychiatric care competitor, though much broader in scope than The London Psychiatry Centre's specialist outpatient focus.
• Cygnet Health Care: UK provider of mental health, learning disability, and autism services across hospitals, residential settings, and community programmes. Comparable as a competing UK mental health services operator with overlapping patient populations.

Regional players

• Harley Street Specialist Hospital: Harley Street-based private hospital offering outpatient consultations and day-case procedures across multiple specialties. Comparable as a London private healthcare operator sharing the same premium medical district, though broader in clinical scope than psychiatry alone.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tlpc_uk
• Facebookfacebook.com/psychiatrycentre
• LinkedInlinkedin.com/company/the-london-psychiatry-centre-llp

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles25 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The London Psychiatry Centre